We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

58 hedge funds and large institutions have $251M invested in Global Cord Blood Corporation in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

16% more funds holding

Funds holding: 5058 (+8)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

4% less capital invested

Capital invested by funds: $261M → $251M (-$9.79M)

64% less call options, than puts

Call options by funds: $461K | Put options by funds: $1.28M

Holders
58
Holders Change
+8
Holders Change %
+16%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
15
Reduced
13
Closed
10
Calls
$461K
Puts
$1.28M
Net Calls
-$823K
Net Calls Change
-$1.28M

CO Hedge Fund Activity: Q1 2018 in Review

58 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2018, worth a combined $251M — down 3.8% from $261M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CO positions and 10 closed out — a net gain of 10 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $12.3M. The largest seller was Skandinaviska Enskilda Banken (SEB), exiting entirely with an estimated $29.2M sold.

  • 58 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2018, up from 50 in Q4 2017.
  • Funds reported $251M of Global Cord Blood Corporation stock for Q1 2018, down 3.8% quarter-over-quarter.
  • 20 funds opened new Global Cord Blood Corporation positions in Q1 2018 and 10 closed out, a net change of +10 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2018 was Vanguard Group, an estimated $12.3M added.
  • The largest Global Cord Blood Corporation seller in Q1 2018 was Skandinaviska Enskilda Banken (SEB), an estimated $29.2M sold.

Based on aggregated 13F filings for Q1 2018.